Parkinson Disease and Complex Parkinsonism

Gene: ATXN2

Red List (low evidence)

ATXN2 (ataxin 2)
EnsemblGeneIds (GRCh38): ENSG00000204842
EnsemblGeneIds (GRCh37): ENSG00000204842
OMIM: 601517, Gene2Phenotype
ATXN2 is in 16 panels

3 reviews

Arina Puzriakova (Genomics England Curator)

Comment on mode of inheritance: Lack of phenotypic relevance for SNVs - nucleotide repeat expansion mechanism
Created: 5 Nov 2021, 3:32 p.m. | Last Modified: 5 Nov 2021, 3:32 p.m.
Panel Version: 1.74

Arianna Tucci (Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square)

Red List (low evidence)

SCA2 expansions may be responsible for a subset of familial parkinsonism, but loss-of-function and missense variants are not relevant in this gene
Created: 14 Dec 2016, 5:27 p.m.

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype -please provide details in the comments

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Would want to promote this to green when STR reporting is possible.
Created: 8 Dec 2016, 3:40 p.m.
Comment on list classification: Expansion repeats may be associated with susceptibility to late-onset Parkinson disease, and the configuration of repeats contributes to the phenotype displayed. As loss-of-function and missense variants are not relevant in this gene, this shoudl remain red.
Created: 2 Nov 2016, 5:12 p.m.
This was submitted as "SCA2" by the expert.
Created: 24 Jul 2015, 11:21 a.m.

History Filter Activity

5 Nov 2021, Gel status: 1

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag currently-ngs-unreportable tag was added to gene: ATXN2.

5 Nov 2021, Gel status: 1

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: ATXN2 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to Other

5 Nov 2021, Gel status: 1

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: ATXN2 were changed from (CAGexpansion); familial parkinsonism to {Parkinson disease, late-onset, susceptibility to}, OMIM:168600

19 Dec 2016, Gel status: 1

panel promoted to version 1

Ellen McDonagh (Genomics England Curator)

19th Dec 2016: panel revised according to expert review and further curation.

15 Dec 2016, Gel status: 1

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for ATXN2 were set to (CAGexpansion);familial parkinsonism

15 Dec 2016, Gel status: 1

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for ATXN2 was changed to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

8 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

2 Nov 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

2 Nov 2016, Gel status: 1

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for ATXN2 was changed to Other - please provide details in the comments

2 Nov 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

19 Oct 2016, Gel status: 0

Added New Source

Ellen McDonagh (Genomics England Curator)

ATXN2 was added to Parkinson Disease and Complex Parkinsonismpanel. Sources: Expert

19 Oct 2016, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

ATXN2 was created by ellenmcdonagh